Literature DB >> 12917790

Medical therapy of endometriosis.

David L Olive1.   

Abstract

The medical treatment of endometriosis is a critical aspect of the therapeutic approach to this disease. Past methods have been based upon systemic hormonal alterations, resulting in suppression of this estrogen-responsive disorder. Treatments such as danazol, progestogens, oral contraceptives, GnRH-agonists, and gestrinone achieve their effects upon endometriosis via this method. However, with a growing understanding of the pathogenesis of this disease, more precise molecular targets for treatment have been identified. Thus, a series of newer agents are under development and hold the potential of greater efficacy and flexibility than traditional treatments. This review analyzes the available and experimental medical treatments of endometriosis, their utility in the treatment of pain and infertility, and their role in the future.

Entities:  

Mesh:

Year:  2003        PMID: 12917790     DOI: 10.1055/s-2003-41327

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  8 in total

1.  Genetic variation in the sex hormone metabolic pathway and endometriosis risk: an evaluation of candidate genes.

Authors:  Britton Trabert; Stephen M Schwartz; Ulrike Peters; Anneclaire J De Roos; Chu Chen; Delia Scholes; Victoria L Holt
Journal:  Fertil Steril       Date:  2011-09-28       Impact factor: 7.329

2.  Endometriosis causing lower extremity deep vein thrombosis - case report and review of the literature.

Authors:  Rajinder P Sharma; Fadi Delly; Horia Marin; Scott Sturza
Journal:  Int J Angiol       Date:  2009

Review 3.  Hormonal treatments for endometriosis: The endocrine background.

Authors:  Silvia Vannuccini; Sara Clemenza; Margherita Rossi; Felice Petraglia
Journal:  Rev Endocr Metab Disord       Date:  2021-08-17       Impact factor: 9.306

4.  LC-MS/MS detection of increased androstenedione levels in patients receiving danazol therapy.

Authors:  Verena Gounden; Diala El-Maouche; Brian R Stolze; Ranganath Muniyappa; Steven J Soldin
Journal:  Ther Drug Monit       Date:  2014-12       Impact factor: 3.681

Review 5.  Ovarian cancer in endometriosis: epidemiology, natural history, and clinical diagnosis.

Authors:  Hiroshi Kobayashi
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

6.  A recurrence-predicting prognostic factor for patients with ovarian clear-cell adenocarcinoma at reproductive age.

Authors:  Hiroaki Kajiyama; Mika Mizuno; Kiyosumi Shibata; Tomokazu Umezu; Shiro Suzuki; Eiko Yamamoto; Hiroko Mitsui; Ryuichiro Sekiya; Kaoru Niimi; Michiyasu Kawai; Tetsuro Nagasaka; Fumitaka Kikkawa
Journal:  Int J Clin Oncol       Date:  2013-12-05       Impact factor: 3.402

7.  Catamenial pneumothorax in a 14-year-old female: A case report and literature review.

Authors:  Andrew W Kramer; Maria Bautista
Journal:  Respir Med Case Rep       Date:  2019-10-14

Review 8.  Screening, epidemiology, molecular biology, and treatment strategies for endometriosis-associated ovarian cancer.

Authors:  Hiroshi Kobayashi
Journal:  Reprod Med Biol       Date:  2009-09-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.